Parexel launches IMPACT Express clinical trial management system

Published: 1-Dec-2015
Regulatory

Simplifies clinical trial management and monitoring for small-to-mid-sized biopharmaceutical companies


Parexel International, a global biopharmaceutical services provider, has introduced the IMPACT Express Clinical Trial Management System (CTMS), which simplifies clinical trial management and monitoring for small- to mid-sized biopharmaceutical companies.

The firm says a single, unified clinical trial management system can play a vital role in helping biopharmaceutical companies plan, track, record, and oversee the complex array of administrative, financial, site-related, and other activities that are critical for the efficient monitoring and management of clinical trials.

'Parexel developed IMPACT Express for biopharmaceutical and biotech companies in need of a scalable, rapid-to-deploy and cost-effective CTMS option to intelligently manage the complexities of clinical trials,' said Patrick Nadolny, Vice President of Product Management, Data and Analytics Services, Parexel Informatics. 'By applying a process-driven approach to trial management and monitoring, biopharma companies will be better able to save time – and money – while simplifying their drug development journey.'

  • Companies:
  • Parexel International
See more

You may also like

Regulatory

Innovation in clinical trials

Read more
Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, following the rise of the IoT (Internet of Things), the pharma industry is poised for even more change

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and infections, provide patients with a better understanding of their ailment and how it might be managed and changed with treatment
  3. Post-Brexit border paperwork and inspections postponed for life sciences sector The six month extension will allow life science companies to the make necessary alterations to their supply chains to accommodate for the novel post-Brexit border paperwork
  4. PCI Pharma Services PCI Pharma Services: Your bridge between life-changing therapies and patients.
  5. How to proactively address EU HTAR implementation challenges before 2025 Data landscape challenges within the European Union (EU) have historically been driven by the different laws, processes and regulatory standards of its 27 member states (MS). As a result, drug therapeutics and health technology developers have faced the challenge of duplication of assessment efforts

Upcoming event

Interphex

16-18 April 2024 | Conference and Exhibition | New York, US See all

You may also like

Regulatory

Innovation in clinical trials

Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, following the rise of the IoT (Internet of Things), the pharma industry is poised for even more change
Regulatory

PAREXEL announces definitive agreement to acquire The Medical Affairs Company

Acquisition will strengthen and add scale to current commercialisation and medical affairs services
Regulatory

PAREXEL launches IDMP-focused software and service solution

Solution developed to help biopharmaceutical companies meet emerging regulatory requirements ahead of deadline
Regulatory

Parexel and EMC to provide cloud-based document and regulatory information management services

Parexel enhances Regulatory Cloud and leverages EMC Documentum for Life Sciences software to offer regulatory solution
Regulatory

Opinion: Between a rock and a hard place

The tragic death of a healthy volunteer in a Phase I clinical trial emphasises how little we really know about the human organism
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Incorporating CMOs into the clinical trial supply chain

The clinical supply chain involves working with several outsourced partners. Jens Mattuschka, Vice President, CLS Worldwide Operations, Parexel International, looks at core planning to reduce the risk of failure
Regulatory

Parexel acquires ClinIntel

Extending its clinical randomisation and trial supply management services
Subscribe now